The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Australian natural skincare company Skin Elements (SKN) has secured a $20 million funding facility with LDA Capital
  • Under the agreement, Skin Elements will issue shares to LDA Capital over the next three years at a floor price determined by Skin Elements
  • Funds from the agreement will give the company ready access to additional equity to support both its growth into new markets and existing channels
  • On the market, Skin Elements last traded at 10 cents per share

Skin Elements (SKN) has secured a $20 million funding facility with LDA Capital.

The parties have signed a put option agreement, which will see LDA provide Skin Elements up to $20 million in committed equity capital over the next 36 months.

Under the agreement, Skin Elements will issue shares to LDA Capital over the next three years at a floor price determined by Skin Elements and will receive funds for the issue of those shares.

Funds from the agreement will give the company ready access to additional equity to support both its growth into new markets and existing channels.

Last year, the natural skincare company applied for a Therapeutic Goods Administration (TGA) registration for its sanitising disinfectant, Invisi Shield — a hospital-grade disinfectant.

“Successful registration with the TGA will allow the company to make more
detailed and specific product and label claims in respect to Invisi Shield which has the potential to open up significant new commercial-scale sales and distribution opportunities,” the company explained to the market.

“We are excited to have secured this $20 million equity funding facility from LDA Capital,” Chairman Peter Malone said.

“LDA Capital has a track record of providing funding to help emerging growth
companies achieve their business goals, and we are delighted to see that LDA Capital shares the same positive view on the global growth potential of our Invisi Shield sanitising disinfectant and our range of natural skincare products as we do,” he added.

On the market, Skin Elements is suspended and last traded at 10 cents per share.

SKN by the numbers
More From The Market Online

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M

WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair…

Genetic Signatures wins TGA greenlight for flu test device – just before winter

Genetic Signatures (ASX:GSS) shares were down -1.45% to 68cps on Monday, even as the company reported…

PYC Therapeutics takes Polycystic Kidney Disease drug to human trials

PYC Therapeutics takes its latest drug for Polycystic Kidney Disease, characterized by the formation of cysts…